LNA Santé SA (EPA:LNA)
France
· Delayed Price · Currency is EUR 26.10
-0.20 (-0.76%)
Mar 9, 2026, 5:37 PM CET
LNA Santé Revenue
LNA Santé had revenue of 446.44M EUR in the half year ending June 30, 2025, with 22.76% growth. This brings the company's revenue in the last twelve months to 863.42M, up 13.31% year-over-year. In the year 2024, LNA Santé had annual revenue of 806.60M with 9.58% growth.
Revenue (ttm)
863.42M
Revenue Growth
+13.31%
P/S Ratio
0.31
Revenue / Employee
104.25K
Employees
8,282
Market Cap
269.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 806.60M | 70.52M | 9.58% |
| Dec 31, 2023 | 736.09M | 7.86M | 1.08% |
| Dec 31, 2022 | 728.22M | 38.73M | 5.62% |
| Dec 31, 2021 | 689.49M | 115.60M | 20.14% |
| Dec 31, 2020 | 573.89M | 46.03M | 8.72% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Genfit | 45.13M |
| Eurobio Scientific Société anonyme | 162.47M |
| Cellectis | 70.36M |
| Transgene | 7.58M |